drugset / Trial / NCT03528070

A Clinical Study of Tranilast in the Treatment of Sarcoidosis

NCT03528070

NaSingle-groupOpen-labelTreatment

Summary

56 patients with sarcoidosis will be selected to receive treatment of tranilast.The investigators can analyse the changes in the thickness and area of skin lesions before and after treatment as well as other involved organs nodule size changes to determine the efficacy and safety of drugs.

Timeline

Start
2018-05
Primary completion
2020-05
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranilast Small molecule 0.1 g

Indications